Harding Thomas C. 4
4 · Clovis Oncology, Inc. · Filed Sep 6, 2022
Insider Transaction Report
Form 4
Harding Thomas C.
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-09-01+2,896→ 19,260 total - Sale
Common Stock
2022-09-02$1.20/sh−172$206→ 3,674 total(indirect: By Spouse) - Exercise/Conversion
Restricted Stock Units
2022-09-01+508→ 3,047 total(indirect: By Spouse)→ Common Stock (508 underlying) - Exercise/Conversion
Common Stock
2022-09-01+508→ 3,846 total(indirect: By Spouse) - Sale
Common Stock
2022-09-02$1.20/sh−1,444$1,733→ 17,816 total - Exercise/Conversion
Restricted Stock Units
2022-09-01+2,896→ 28,958 total→ Common Stock (2,896 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit represents the right to receive one share of Common Stock.
- [F2]Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person.
- [F3]On March 1, 2021, the reporting person was granted 46,334 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2022, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
- [F4]On March 1, 2021, the reporting person's wife was granted 6,090 Restricted Stock Units. 33.3% of such Restricted Stock Units vested on March 1, 2022, and the remainder vests in substantially equal installments over the 8 quarters immediately following such date.